These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 37817743)
41. The Impact of Highly Effective Cystic Fibrosis Transmembrane Conductance Regulator Modulators on the Health of Female Subjects With Cystic Fibrosis. Taylor-Cousar JL; Shteinberg M; Cohen-Cymberknoh M; Jain R Clin Ther; 2023 Mar; 45(3):278-289. PubMed ID: 36841738 [TBL] [Abstract][Full Text] [Related]
43. Personalized medicine in cystic fibrosis: genistein supplementation as a treatment option for patients with a rare S1045Y-CFTR mutation. Arora K; Yarlagadda S; Zhang W; Moon C; Bouquet E; Srinivasan S; Li C; Stokes DC; Naren AP Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L364-74. PubMed ID: 27261451 [TBL] [Abstract][Full Text] [Related]
44. Development, clinical utility, and place of ivacaftor in the treatment of cystic fibrosis. O'Reilly R; Elphick HE Drug Des Devel Ther; 2013; 7():929-37. PubMed ID: 24039402 [TBL] [Abstract][Full Text] [Related]
45. Prenatal Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy: A Promising Way to Change the Impact of Cystic Fibrosis. Gómez-Montes E; Salcedo Lobato E; Galindo Izquierdo A; García Alcázar D; Villalain González C; Moral-Pumarega MT; Bustos Lozano G; Luna-Paredes C Fetal Diagn Ther; 2023; 50(2):136-142. PubMed ID: 36996799 [TBL] [Abstract][Full Text] [Related]
46. The preclinical discovery and development of the combination of ivacaftor + tezacaftor used to treat cystic fibrosis. Guerra L; Favia M; Di Gioia S; Laselva O; Bisogno A; Casavola V; Colombo C; Conese M Expert Opin Drug Discov; 2020 Aug; 15(8):873-891. PubMed ID: 32290721 [TBL] [Abstract][Full Text] [Related]
52. A mutation in the cystic fibrosis transmembrane conductance regulator gene associated with elevated sweat chloride concentrations in the absence of cystic fibrosis. Mickle JE; Macek M; Fulmer-Smentek SB; Egan MM; Schwiebert E; Guggino W; Moss R; Cutting GR Hum Mol Genet; 1998 Apr; 7(4):729-35. PubMed ID: 9499426 [TBL] [Abstract][Full Text] [Related]
53. Differences in gene mutations between Chinese and Caucasian cystic fibrosis patients. Zheng B; Cao L Pediatr Pulmonol; 2017 Mar; 52(3):E11-E14. PubMed ID: 27717243 [TBL] [Abstract][Full Text] [Related]
54. Transcriptomic and Proteostasis Networks of CFTR and the Development of Small Molecule Modulators for the Treatment of Cystic Fibrosis Lung Disease. Strub MD; McCray PB Genes (Basel); 2020 May; 11(5):. PubMed ID: 32414011 [TBL] [Abstract][Full Text] [Related]
55. Cystic fibrosis transmembrane conductance regulator modulators: the end of the beginning. Barry PJ; Ronan N; Plant BJ Semin Respir Crit Care Med; 2015 Apr; 36(2):287-98. PubMed ID: 25826594 [TBL] [Abstract][Full Text] [Related]
56. New pharmacological approaches for cystic fibrosis: promises, progress, pitfalls. Bell SC; De Boeck K; Amaral MD Pharmacol Ther; 2015 Jan; 145():19-34. PubMed ID: 24932877 [TBL] [Abstract][Full Text] [Related]
57. Cystic fibrosis patients of minority race and ethnicity less likely eligible for CFTR modulators based on CFTR genotype. McGarry ME; McColley SA Pediatr Pulmonol; 2021 Jun; 56(6):1496-1503. PubMed ID: 33470563 [TBL] [Abstract][Full Text] [Related]
58. Current and novel therapeutic strategies for the management of cystic fibrosis. Gbian DL; Omri A Expert Opin Drug Deliv; 2021 May; 18(5):535-552. PubMed ID: 33426936 [No Abstract] [Full Text] [Related]
59. Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis. Patel S; Sinha IP; Dwan K; Echevarria C; Schechter M; Southern KW Cochrane Database Syst Rev; 2015 Mar; (3):CD009841. PubMed ID: 25811419 [TBL] [Abstract][Full Text] [Related]
60. Unique mutations of the cystic fibrosis transmembrane conductance regulator gene of three cases of cystic fibrosis in Nagasaki, Japan. Izumikawa K; Tomiyama Y; Ishimoto H; Sakamoto N; Imamura Y; Seki M; Sawai T; Kakeya H; Yamamoto Y; Yanagihara K; Mukae H; Yoshimura K; Kohno S Intern Med; 2009; 48(15):1327-31. PubMed ID: 19652440 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]